Loading...
Explore Pramodini Medicare SME IPO details, including IPO dates, financial statements, valuation, peer comparison and more.
Pramodini Medicare Limited is an Indian diagnostic healthcare service provider offering technology-enabled services across radiology, clinical laboratory, and nuclear medicine. The company serves a diverse clientele, including government and private hospitals, public sector undertakings (PSUs), medical colleges, private diagnostic centres, and individual patients across Tier I, II, and III cities.
Main Products and Services The company’s diagnostic portfolio includes MRI, CT scans, X-rays, ultrasound with colour Doppler, mammography, DEXA scans, interventional radiology, pathology, biochemistry, microbiology, immunology, haematology, PET-CT, SPECT, and nuclear therapy. Additionally, it operates a 24×7 teleradiology centre and a central processing laboratory in Vijayawada.
Key Highlights
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 12 Aug - 14 Aug 2026 |
| IPO Price Band | ₹110 - ₹118 per share |
| Fresh Issue | ₹59.17 crore |
| Offer For Sale | ₹5.90 crore |
| Total IPO Size | ₹69.04 crore |
| Face Value | ₹10 |
| Listing On | NSE SME |
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 12 Aug 2026 |
| IPO Closing Date | 14 Aug 2026 |
| Basis Of Allotment | 17 Aug 2026 |
| Refunds | 18 Aug 2026 |
| Demat Transfer | 18 Aug 2026 |
| IPO Listing Date | 19 Aug 2026 |
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31 Mar 2024 | 31 Mar 2025 | 31 Mar 2026 |
|---|---|---|---|
| Assets | 48.78 | 56.45 | 93.62 |
| Total Income | 35.79 | 38.55 | 63.38 |
| Profit After Tax | 7.14 | 11.14 | 17.38 |
| EBITDA | 15.53 | 20.97 | 30.90 |
| NET Worth | 24.75 | 35.77 | 53.15 |
| Reserves and Surplus | 23.46 | 34.49 | 36.46 |
| Total Borrowing | 11.96 | 10.81 | 17.85 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Compare key financial metrics with industry peers to gain valuable insights into the company's performance compared to its competitors.
| Name | P/E | EPS | RoNW | NAV |
|---|---|---|---|---|
| Pramodini Medicare Ltd. | 11.34 | 10.41 | 32.69% | 31.84 |
| Star Imaging & Path Labs Ltd. | 7.87 | 11.05 | 16.58% | 66.65 |
| Krsnaa Diagnostics Ltd. | 16.74 | 31.3 | 10.35% | 302.23 |
| Invicta Diagnostic Ltd. | 13.62 | 4.9 | 9.76% | 39.71 |
* Revenue in (₹cr), RoNW in (%), EPS, NAV in (₹). P/E ratio is based on the highest price from the IPO price band.
| Investor Type | Shares Offered |
|---|---|
| Retail Individual Investor (RII) | 20,23,200 |
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 3.66 |
| Non-Institutional Investor (NII/HNI) | 4.96 |
| Retail Individual Investor (RII) | 3.49 |
| Total | 3.87 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
Purva Sharegistry (India) Private Limited
Phone: +91 022 4961 4132/3190 8810
Email: newissue@purvashare.com
Website: www.purvashare.com
Pramodini Medicare Ltd.D. No: - 29-4-54K, CSI Complex,
Prakasam Road,
Suryaraopet
Vijayawada, Andhra Pradesh – 520002
Website: https://www.pramodinidiagnostics.com/
Phone: +91 9985782727